These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4234690)

  • 1. Experimental immunity against tuberculosis evoked by peptidoglycolipids of the wax D type.
    Pokorný J; Sulová J; Zák F
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Aug; 136(2):118-28. PubMed ID: 4234690
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modification of the biologic test for tuberculosis with silica-treated guinea pigs.
    Derubska B
    Arch Immunol Ther Exp (Warsz); 1967; 15(2):204-21. PubMed ID: 4292935
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical usefulness of rapid serodiagnosis in pulmonary tuberculosis by ELISA with glycolipidic antigens extracted from Mycobacterium tuberculosis and with whole BCG suspension.
    Niculescu D; Stavri H; Teodor I; Popa M; Stavri D; Ciomu E; Homoş M; Popescu L
    Roum Arch Microbiol Immunol; 1995; 54(4):277-84. PubMed ID: 8993121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The feasibility of using the fluorescent antibody technic in immunologic studies of tuberculosis].
    Gogebashvili NV; Averbakh MM
    Biull Eksp Biol Med; 1967 Sep; 64(9):71-4. PubMed ID: 4988303
    [No Abstract]   [Full Text] [Related]  

  • 6. Potency of PPD preparations derived from M. tuberculosis and M. bovis.
    Zsidai J; Csizér Z; Joó I
    Ann Immunol Hung; 1979; 19():63-74. PubMed ID: 121875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis immunity and allergy].
    Kekkaku; 1968 Mar; 43(3):25-8. PubMed ID: 4971117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of delayed-type hypersensitivity in the immunity against tuberculous infection].
    Kalmykova GH
    Probl Tuberk; 1973; 51(1):57-63. PubMed ID: 4199377
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunochemical study of Mycobacteria firmly bound lipids.
    Hiu IJ; Amiel JL; Nikdjou K
    Rev Eur Etud Clin Biol; 1970 Oct; 15(8):887-91. PubMed ID: 4993152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study on measuring the degree of BCG-immunity in guinea pigs by airborne infection].
    Toyohara M; Shimoide H
    Kekkaku; 1967 Dec; 42(12):505-10. PubMed ID: 4877840
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation of an adjuvant-active glycolipid lacking peptide moiety from wax D preparation of Mycobacterium tuberculosis strain aoyama B.
    Kumazawa Y; Shibusawa A; Suzuki T; Mizunoe K
    Immunochemistry; 1976 Feb; 13(2):173-7. PubMed ID: 816734
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterial sensitivity elicited with a PPD devoided of the majority of the antigens common with BCG. Results on healthy-BCG vaccinated and tuberculous children.
    Stavri D; Claiciu I; Bărbulescu R; Stavri H; Niculescu D; Calciu B; Calciu M
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):221-6. PubMed ID: 6424630
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunology of tuberculosis.
    Collins FM
    Am Rev Respir Dis; 1982 Mar; 125(3 Pt 2):42-9. PubMed ID: 6803632
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serologic activity of purified phospholipids of Mycobacterium tuberculosis].
    Sasaki A; Takahashi Y
    C R Seances Soc Biol Fil; 1974; 168(4-5):626-9. PubMed ID: 4281705
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs.
    Dworski M
    Am Rev Respir Dis; 1973 Aug; 108(2):294-300. PubMed ID: 4578541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on adjuvant activity of wax D fraction of mycobacteria].
    Someya S
    Kekkaku; 1968 Aug; 43(8):328-31. PubMed ID: 4974528
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical composition and antigenicity of a residual protein of Mycobacterium tuberculosis.
    Tsumita T; Arita M; Kanai K
    Jpn J Exp Med; 1970 Aug; 40(4):283-93. PubMed ID: 4991650
    [No Abstract]   [Full Text] [Related]  

  • 18. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity of wax D, a peptidoglycolipid of M. tuberculosis. 3. Prliminary report on the clinical evaluation of wax D agglutination as a sero-diagnostic test for pulmonary tuberculosis.
    Tanaka A; Hirota N; Sugiyama K
    Int Arch Allergy Appl Immunol; 1967; 32(3):349-52. PubMed ID: 6073629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.